{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:26:01Z","timestamp":1791296761708,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,10,19]],"date-time":"2015-10-19T00:00:00Z","timestamp":1445212800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico (CNPq)","award":["n\u00b0552721\/2011-5"],"award-info":[{"award-number":["n\u00b0552721\/2011-5"]}]},{"name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico (CNPq)","award":["483540\/2011-0"],"award-info":[{"award-number":["483540\/2011-0"]}]},{"name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior (Capes),","award":["N\u00ba 032\/2010 (ARJ)"],"award-info":[{"award-number":["N\u00ba 032\/2010 (ARJ)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasitol Res"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1007\/s00436-015-4793-4","type":"journal-article","created":{"date-parts":[[2015,10,18]],"date-time":"2015-10-18T23:03:18Z","timestamp":1445209398000},"page":"713-721","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Cross-resistance of Leishmania infantum isolates to nitric oxide from patients refractory to antimony treatment, and greater tolerance to antileishmanial responses by macrophages"],"prefix":"10.1007","volume":"115","author":[{"given":"Tatiana R.","family":"de Moura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micheli Luize Barbosa","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juciene M.","family":"Braz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Felipe V. C.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matheus T.","family":"Arag\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabricia A.","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscila L.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c2ngela Maria","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Am\u00e9lia Ribeiro","family":"de Jesus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roque P.","family":"de Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,19]]},"reference":[{"key":"4793_CR1","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1007\/s00436-011-2555-5","volume":"109","author":"K Ait-Oudhia","year":"2011","unstructured":"Ait-Oudhia K, Gazanion E, Vergnes B, Oury B, Sereno D (2011) Leishmania antimony resistance: what we know what we can learn from the field. Parasitol Res 109:1225\u20131232. doi: 10.1007\/s00436-011-2555-5","journal-title":"Parasitol Res"},{"key":"4793_CR2","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/eji.1830240328","volume":"24","author":"J Assreuy","year":"1994","unstructured":"Assreuy J, Cunha FQ, Epperlein M, Noronha-Dutra A, O\u2019Donnell CA, Liew FY, Moncada S (1994) Production of nitric oxide and superoxide by activated macrophages and killing of Leishmania major. Eur J Immunol 24:672\u2013676. doi: 10.1002\/eji.1830240328","journal-title":"Eur J Immunol"},{"key":"4793_CR3","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1056\/NEJM199001043220104","volume":"322","author":"R Badaro","year":"1990","unstructured":"Badaro R, Falcoff E, Badaro FS, Carvalho EM, Pedral-Sampaio D, Barral A, Carvalho JS, Barral-Netto M, Brandely M, Silva L et al (1990) Treatment of visceral leishmaniasis with pentavalent antimony and interferon gamma. N Engl J Med 322:16\u201321. doi: 10.1056\/NEJM199001043220104","journal-title":"N Engl J Med"},{"key":"4793_CR4","first-page":"359","volume":"8","author":"M Bagher Khadem Erfan","year":"2013","unstructured":"Bagher Khadem Erfan M, Mohebali M, Kazemi-Rad E, Hajjaran H, Edrissian G, Mamishi S, Saffari M, Raoofian R, Heidari M (2013) Downregulation of calcineurin gene is associated with glucantime ((R)) resiatance in leishmania infantum. Iran J Parasitol 8:359\u2013366","journal-title":"Iran J Parasitol"},{"key":"4793_CR5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1471-2210-2-11","volume":"2","author":"J Carrio","year":"2002","unstructured":"Carrio J, Portus M (2002) In vitro susceptibility to pentavalent antimony in Leishmania infantum strains is not modified during in vitro or in vivo passages but is modified after host treatment with meglumine antimoniate. BMC Pharmacol 2:11","journal-title":"BMC Pharmacol"},{"key":"4793_CR6","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0001-706X(01)00125-5","volume":"79","author":"J Carrio","year":"2001","unstructured":"Carrio J, Riera C, Gallego M, Portus M (2001) In vitro activity of pentavalent antimony derivatives on promastigotes and intracellular amastigotes of Leishmania infantum strains from humans and dogs in Spain. Acta Trop 79:179\u2013183","journal-title":"Acta Trop"},{"key":"4793_CR7","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1128\/AAC.47.5.1529-1535.2003","volume":"47","author":"KC Carter","year":"2003","unstructured":"Carter KC, Sundar S, Spickett C, Pereira OC, Mullen AB (2003) The in vivo susceptibility of Leishmania donovani to sodium stibogluconate is drug specific and can be reversed by inhibiting glutathione biosynthesis. Antimicrob Agents Chemother 47:1529\u20131535","journal-title":"Antimicrob Agents Chemother"},{"key":"4793_CR8","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1128\/AAC.50.1.88-95.2006","volume":"50","author":"KC Carter","year":"2006","unstructured":"Carter KC, Hutchison S, Henriquez FL, Legare D, Ouellette M, Roberts CW, Mullen AB (2006) Resistance of Leishmania donovani to sodium stibogluconate is related to the expression of host and parasite gamma-glutamylcysteine synthetase. Antimicrob Agents Chemother 50:88\u201395. doi: 10.1128\/AAC.50.1.88-95.2006","journal-title":"Antimicrob Agents Chemother"},{"key":"4793_CR9","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1365-2249.2008.03741.x","volume":"154","author":"D Chandra","year":"2008","unstructured":"Chandra D, Naik S (2008) Leishmania donovani infection down-regulates TLR2-stimulated IL-12p40 and activates IL-10 in cells of macrophage\/monocytic lineage by modulating MAPK pathways through a contact-dependent mechanism. Clin Exp Immunol 154:224\u2013234. doi: 10.1111\/j.1365-2249.2008.03741.x","journal-title":"Clin Exp Immunol"},{"key":"4793_CR10","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1126\/science.257.5073.1050","volume":"257","author":"ML Cohen","year":"1992","unstructured":"Cohen ML (1992) Epidemiology of drug resistance: implications for a post-antimicrobial era. Science 257:1050\u20131055","journal-title":"Science"},{"key":"4793_CR11","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1128\/CMR.19.1.111-126.2006","volume":"19","author":"SL Croft","year":"2006","unstructured":"Croft SL, Sundar S, Fairlamb AH (2006) Drug resistance in leishmaniasis. Clin Microbiol Rev 19:111\u2013126. doi: 10.1128\/CMR.19.1.111-126.2006","journal-title":"Clin Microbiol Rev"},{"key":"4793_CR12","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00436-013-3621-y","volume":"113","author":"AF Azevedo de","year":"2014","unstructured":"de Azevedo AF, Dutra JL, Santos ML, Santos Dde A, Alves PB, de Moura TR, de Almeida RP, Fernandes MF, Scher R, Fernandes RP (2014) Fatty acid profiles in Leishmania spp. isolates with natural resistance to nitric oxide and trivalent antimony. Parasitol Res 113:19\u201327. doi: 10.1007\/s00436-013-3621-y","journal-title":"Parasitol Res"},{"key":"4793_CR13","doi-asserted-by":"crossref","first-page":"319234","DOI":"10.1155\/2013\/319234","volume":"2013","author":"EC Melo de","year":"2013","unstructured":"de Melo EC, Fortaleza CM (2013) Challenges in the therapy of visceral leishmaniasis in Brazil: a public health perspective. J Trop Med 2013:319234. doi: 10.1155\/2013\/319234","journal-title":"J Trop Med"},{"key":"4793_CR14","doi-asserted-by":"crossref","first-page":"4616","DOI":"10.1128\/AAC.49.11.4616-4621.2005","volume":"49","author":"S Decuypere","year":"2005","unstructured":"Decuypere S, Rijal S, Yardley V, De Doncker S, Laurent T, Khanal B, Chappuis F, Dujardin JC (2005) Gene expression analysis of the mechanism of natural Sb (V) resistance in Leishmania donovani isolates from Nepal. Antimicrob Agents Chemother 49:4616\u20134621","journal-title":"Antimicrob Agents Chemother"},{"key":"4793_CR15","doi-asserted-by":"crossref","first-page":"e1514","DOI":"10.1371\/journal.pntd.0001514","volume":"6","author":"S Decuypere","year":"2012","unstructured":"Decuypere S, Vanaerschot M, Brunker K, Imamura H, Muller S, Khanal B, Rijal S, Dujardin JC, Coombs GH (2012) Molecular mechanisms of drug resistance in natural Leishmania populations vary with genetic background. PLoS Negl Trop Dis 6:e1514","journal-title":"PLoS Negl Trop Dis"},{"key":"4793_CR16","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/jac\/44.1.71","volume":"44","author":"C Giorgio Di","year":"1999","unstructured":"Di Giorgio C, Faraut-Gambarelli F, Imbert A, Minodier P, Gasquet M, Dumon H (1999) Flow cytometric assessment of amphotericin B susceptibility in Leishmania infantum isolates from patients with visceral leishmaniasis. J Antimicrob Chemother 44:71\u201376","journal-title":"J Antimicrob Chemother"},{"key":"4793_CR17","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0001-706X(01)00197-8","volume":"81","author":"P Escobar","year":"2002","unstructured":"Escobar P, Matu S, Marques C, Croft SL (2002) Sensitivities of Leishmania species to hexadecylphosphocholine (miltefosine), ET-18-OCH (3) (edelfosine) and amphotericin B. Acta Trop 81:151\u2013157","journal-title":"Acta Trop"},{"key":"4793_CR18","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1128\/AAC.41.4.827","volume":"41","author":"F Faraut-Gambarelli","year":"1997","unstructured":"Faraut-Gambarelli F, Piarroux R, Deniau M, Giusiano B, Marty P, Michel G, Faugere B, Dumon H (1997) In vitro and in vivo resistance of Leishmania infantum to meglumine antimoniate: a study of 37 strains collected from patients with visceral leishmaniasis. Antimicrob Agents Chemother 41:827\u2013830","journal-title":"Antimicrob Agents Chemother"},{"key":"4793_CR19","doi-asserted-by":"crossref","first-page":"6403","DOI":"10.4049\/jimmunol.163.12.6403","volume":"163","author":"GJ Feng","year":"1999","unstructured":"Feng GJ, Goodridge HS, Harnett MM, Wei XQ, Nikolaev AV, Higson AP, Liew FY (1999) Extracellular signal-related kinase (ERK) and p38 mitogen-activated protein (MAP) kinases differentially regulate the lipopolysaccharide-mediated induction of inducible nitric oxide synthase and IL-12 in macrophages: Leishmania phosphoglycans subvert macrophage IL-12 production by targeting ERK MAP kinase. J Immunol 163:6403\u20136412","journal-title":"J Immunol"},{"key":"4793_CR20","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.arcmed.2005.07.011","volume":"37","author":"M Genestra","year":"2006","unstructured":"Genestra M, Guedes-Silva D, Souza WJ, Cysne-Finkelstein L, Soares-Bezerra RJ, Monteiro FP, Leon LL (2006) Nitric oxide synthase (NOS) characterization in Leishmania amazonensis axenic amastigotes. Arch Med Res 37:328\u2013333","journal-title":"Arch Med Res"},{"key":"4793_CR21","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2334-7-7","volume":"7","author":"A Giudice","year":"2007","unstructured":"Giudice A, Camada I, Leopoldo PT, Pereira JM, Riley LW, Wilson ME, Ho JL, de Jesus AR, Carvalho EM, Almeida RP (2007) Resistance of Leishmania (Leishmania) amazonensis and Leishmania (Viannia) braziliensis to nitric oxide correlates with disease severity in tegumentary leishmaniasis. BMC Infect Dis 7:7","journal-title":"BMC Infect Dis"},{"key":"4793_CR22","doi-asserted-by":"crossref","first-page":"4503","DOI":"10.1128\/AAC.01075-08","volume":"52","author":"DA Goyeneche-Patino","year":"2008","unstructured":"Goyeneche-Patino DA, Valderrama L, Walker J, Saravia NG (2008) Antimony resistance and trypanothione in experimentally selected and clinical strains of Leishmania panamensis. Antimicrob Agents Chemother 52:4503\u20134506. doi: 10.1128\/AAC.01075-08","journal-title":"Antimicrob Agents Chemother"},{"key":"4793_CR23","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1080\/00034983.1992.11812717","volume":"86","author":"M Gramiccia","year":"1992","unstructured":"Gramiccia M, Gradoni L, Orsini S (1992) Decreased sensitivity to meglumine antimoniate (Glucantime) of Leishmania infantum isolated from dogs after several courses of drug treatment. Ann Trop Med Parasitol 86:613\u2013620","journal-title":"Ann Trop Med Parasitol"},{"key":"4793_CR24","doi-asserted-by":"crossref","first-page":"4406","DOI":"10.1128\/AAC.49.10.4406-4409.2005","volume":"49","author":"P Holzmuller","year":"2005","unstructured":"Holzmuller P, Sereno D, Lemesre JL (2005) Lower nitric oxide susceptibility of trivalent antimony-resistant amastigotes of Leishmania infantum. Antimicrob Agents Chemother 49:4406\u20134409","journal-title":"Antimicrob Agents Chemother"},{"key":"4793_CR25","doi-asserted-by":"crossref","first-page":"4866","DOI":"10.1128\/AAC.02521-13","volume":"58","author":"F Jeddi","year":"2014","unstructured":"Jeddi F, Mary C, Aoun K, Harrat Z, Bouratbine A, Faraut F, Benikhlef R, Pomares C, Pratlong F, Marty P, Piarroux R (2014) Heterogeneity of molecular resistance patterns in antimony-resistant field isolates of Leishmania species from the Western Mediterranean area. Antimicrob Agents Chemother 58:4866\u20134874. doi: 10.1128\/AAC.02521-13","journal-title":"Antimicrob Agents Chemother"},{"key":"4793_CR26","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.parint.2006.10.005","volume":"56","author":"H Kothari","year":"2007","unstructured":"Kothari H, Kumar P, Sundar S, Singh N (2007) Possibility of membrane modification as a mechanism of antimony resistance in Leishmania donovani. Parasitol Int 56:77\u201380. doi: 10.1016\/j.parint.2006.10.005","journal-title":"Parasitol Int"},{"key":"4793_CR27","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1128\/JCM.40.1.210-215.2002","volume":"40","author":"L Lachaud","year":"2002","unstructured":"Lachaud L, Marchergui-Hammami S, Chabbert E, Dereure J, Dedet JP, Bastien P (2002) Comparison of six PCR methods using peripheral blood for detection of canine visceral leishmaniasis. J Clin Microbiol 40:210\u2013215","journal-title":"J Clin Microbiol"},{"key":"4793_CR28","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/nm.3221","volume":"19","author":"DS Lima-Junior","year":"2013","unstructured":"Lima-Junior DS, Costa DL, Carregaro V, Cunha LD, Silva AL, Mineo TW, Gutierrez FR, Bellio M, Bortoluci KR, Flavell RA, Bozza MT, Silva JS, Zamboni DS (2013) Inflammasome-derived IL-1beta production induces nitric oxide-mediated resistance to Leishmania. Nat Med 19:909\u2013915","journal-title":"Nat Med"},{"key":"4793_CR29","doi-asserted-by":"crossref","first-page":"6355","DOI":"10.1128\/IAI.68.11.6355-6361.2000","volume":"68","author":"MV Lonardoni","year":"2000","unstructured":"Lonardoni MV, Russo M, Jancar S (2000) Essential role of platelet-activating factor in control of Leishmania (Leishmania) amazonensis infection. Infect Immun 68:6355\u20136361","journal-title":"Infect Immun"},{"key":"4793_CR30","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/eji.1830170209","volume":"17","author":"J Mauel","year":"1987","unstructured":"Mauel J, Buchmuller-Rouiller Y (1987) Effect of lipopolysaccharide on intracellular killing of Leishmania enriettii and correlation with macrophage oxidative metabolism. Eur J Immunol 17:203\u2013208. doi: 10.1002\/eji.1830170209","journal-title":"Eur J Immunol"},{"key":"4793_CR31","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S1383-5769(99)00020-3","volume":"48","author":"J Mikus","year":"2000","unstructured":"Mikus J, Steverding D (2000) A simple colorimetric method to screen drug cytotoxicity against Leishmania using the dye Alamar Blue. Parasitol Int 48:265\u2013269","journal-title":"Parasitol Int"},{"key":"4793_CR32","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/0140-6736(92)92952-C","volume":"340","author":"M Mishra","year":"1992","unstructured":"Mishra M, Biswas UK, Jha DN, Khan AB (1992) Amphotericin versus pentamidine in antimony-unresponsive kala-azar. Lancet 340:1256\u20131257","journal-title":"Lancet"},{"key":"4793_CR33","doi-asserted-by":"crossref","first-page":"681","DOI":"10.4269\/ajtmh.2007.76.681","volume":"76","author":"MK Mittal","year":"2007","unstructured":"Mittal MK, Rai S, Ashutosh R, Gupta S, Sundar S, Goyal N (2007) Characterization of natural antimony resistance in Leishmania donovani isolates. Am J Trop Med Hyg 76:681\u2013688","journal-title":"Am J Trop Med Hyg"},{"key":"4793_CR34","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1128\/AAC.50.5.1788-1797.2006","volume":"50","author":"J Mookerjee Basu","year":"2006","unstructured":"Mookerjee Basu J, Mookerjee A, Sen P, Bhaumik S, Sen P, Banerjee S, Naskar K, Choudhuri SK, Saha B, Raha S, Roy S (2006) Sodium antimony gluconate induces generation of reactive oxygen species and nitric oxide via phosphoinositide 3-kinase and mitogen-activated protein kinase activation in Leishmania donovani-infected macrophages. Antimicrob Agents Chemother 50:1788\u20131797. doi: 10.1128\/AAC.50.5.1788-1797.2006","journal-title":"Antimicrob Agents Chemother"},{"key":"4793_CR35","doi-asserted-by":"crossref","first-page":"E575","DOI":"10.1073\/pnas.1213839110","volume":"110","author":"B Mukherjee","year":"2013","unstructured":"Mukherjee B, Mukhopadhyay R, Bannerjee B, Chowdhury S, Mukherjee S, Naskar K, Allam US, Chakravortty D, Sundar S, Dujardin JC, Roy S (2013) Antimony-resistant but not antimony-sensitive Leishmania donovani up-regulates host IL-10 to overexpress multidrug-resistant protein 1. Proc Natl Acad Sci U S A 110:E575\u2013E582. doi: 10.1073\/pnas.1213839110","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4793_CR36","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.drup.2004.07.002","volume":"7","author":"M Ouellette","year":"2004","unstructured":"Ouellette M, Drummelsmith J, Papadopoulou B (2004) Leishmaniasis: drugs in the clinic, resistance and new developments. Drug Resist Updat 7:257\u2013266. doi: 10.1016\/j.drup.2004.07.002","journal-title":"Drug Resist Updat"},{"key":"4793_CR37","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1128\/AAC.00030-11","volume":"56","author":"B Purkait","year":"2012","unstructured":"Purkait B, Kumar A, Nandi N, Sardar AH, Das S, Kumar S, Pandey K, Ravidas V, Kumar M, De T, Singh D, Das P (2012) Mechanism of amphotericin B resistance in clinical isolates of Leishmania donovani. Antimicrob Agents Chemother 56:1031\u20131041. doi: 10.1128\/AAC.00030-11","journal-title":"Antimicrob Agents Chemother"},{"key":"4793_CR38","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/257393a0","volume":"257","author":"P Ralph","year":"1975","unstructured":"Ralph P, Nakoinz I (1975) Phagocytosis and cytolysis by a macrophage tumour and its cloned cell line. Nature 257:393\u2013394","journal-title":"Nature"},{"key":"4793_CR39","doi-asserted-by":"crossref","first-page":"e584","DOI":"10.1371\/journal.pntd.0000584","volume":"4","author":"GA Romero","year":"2010","unstructured":"Romero GA, Boelaert M (2010) Control of visceral leishmaniasis in latin america-a systematic review. PLoS Negl Trop Dis 4:e584. doi: 10.1371\/journal.pntd.0000584","journal-title":"PLoS Negl Trop Dis"},{"key":"4793_CR40","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.niox.2012.04.004","volume":"27","author":"PL Santos","year":"2012","unstructured":"Santos PL, Costa RV, Braz JM, Santos LF, Batista AC, Vasconcelos CR, Rangel MR, Ribeiro de Jesus A, de Moura TR, Leopoldo PT, Almeida RP (2012) Leishmania chagasi naturally resistant to nitric oxide isolated from humans and dogs with visceral leishmaniasis in Brazil. Nitric Oxide 27:67\u201371. doi: 10.1016\/j.niox.2012.04.004","journal-title":"Nitric Oxide"},{"key":"4793_CR41","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/1471-2334-10-209","volume":"10","author":"AS Souza","year":"2010","unstructured":"Souza AS, Giudice A, Pereira JM, Guimaraes LH, de Jesus AR, de Moura TR, Wilson ME, Carvalho EM, Almeida RP (2010) Resistance of Leishmania (Viannia) braziliensis to nitric oxide: correlation with antimony therapy and TNF-alpha production. BMC Infect Dis 10:209. doi: 10.1186\/1471-2334-10-209","journal-title":"BMC Infect Dis"},{"key":"4793_CR42","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1517\/14656566.2013.755515","volume":"14","author":"S Sundar","year":"2013","unstructured":"Sundar S, Chakravarty J (2013) Leishmaniasis: an update of current pharmacotherapy. Expert Opin Pharmacother 14:53\u201363. doi: 10.1517\/14656566.2013.755515","journal-title":"Expert Opin Pharmacother"},{"key":"4793_CR43","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1086\/318121","volume":"31","author":"S Sundar","year":"2000","unstructured":"Sundar S, More DK, Singh MK, Singh VP, Sharma S, Makharia A, Kumar PC, Murray HW (2000) Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic. Clin Infect Dis 31:1104\u20131107. doi: 10.1086\/318121","journal-title":"Clin Infect Dis"},{"key":"4793_CR44","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1086\/520665","volume":"45","author":"S Sundar","year":"2007","unstructured":"Sundar S, Chakravarty J, Rai VK, Agrawal N, Singh SP, Chauhan V, Murray HW (2007) Amphotericin B treatment for Indian visceral leishmaniasis: response to 15 daily versus alternate-day infusions. Clin Infect Dis 45:556\u2013561. doi: 10.1086\/520665","journal-title":"Clin Infect Dis"},{"key":"4793_CR45","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1590\/S0036-46652008000300005","volume":"50","author":"AC Teixeira","year":"2008","unstructured":"Teixeira AC, Paes MG, Guerra Jde O, Prata A, Silva-Vergara ML (2008) Failure of both azithromycin and antimony to treat cutaneous leishmaniasis in Manaus, AM, Brazil. Rev Inst Med Trop Sao Paulo 50:157\u2013160","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"4793_CR46","doi-asserted-by":"crossref","first-page":"e904","DOI":"10.1371\/journal.pntd.0000904","volume":"4","author":"R t\u2019Kindt","year":"2010","unstructured":"t\u2019Kindt R, Scheltema RA, Jankevics A, Brunker K, Rijal S, Dujardin JC, Breitling R, Watson DG, Coombs GH, Decuypere S (2010) Metabolomics to unveil and understand phenotypic diversity between pathogen populations. PLoS Negl Trop Dis 4:e904. doi: 10.1371\/journal.pntd.0000904","journal-title":"PLoS Negl Trop Dis"},{"key":"4793_CR47","doi-asserted-by":"crossref","first-page":"e23120","DOI":"10.1371\/journal.pone.0023120","volume":"6","author":"M Vanaerschot","year":"2011","unstructured":"Vanaerschot M, De Doncker S, Rijal S, Maes L, Dujardin JC, Decuypere S (2011) Antimonial resistance in Leishmania donovani is associated with increased in vivo parasite burden. PLoS ONE 6:e23120. doi: 10.1371\/journal.pone.0023120","journal-title":"PLoS ONE"},{"key":"4793_CR48","first-page":"68","volume":"15","author":"RC Zauli-Nascimento","year":"2010","unstructured":"Zauli-Nascimento RC, Miguel DC, Yokoyama-Yasunaka JK, Pereira LI, Pelli de Oliveira MA, Ribeiro-Dias F, Dorta ML, Uliana SR (2010) In vitro sensitivity of Leishmania (Viannia) braziliensis and Leishmania (Leishmania) amazonensis Brazilian isolates to meglumine antimoniate and amphotericin B. Trop Med Int Health 15:68\u201376. doi: 10.1111\/j.1365-3156.2009.02414.x","journal-title":"Trop Med Int Health"}],"container-title":["Parasitology Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-015-4793-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00436-015-4793-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-015-4793-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T09:29:14Z","timestamp":1692091754000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00436-015-4793-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,19]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["4793"],"URL":"https:\/\/doi.org\/10.1007\/s00436-015-4793-4","relation":{},"ISSN":["0932-0113","1432-1955"],"issn-type":[{"value":"0932-0113","type":"print"},{"value":"1432-1955","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,19]]}}}